Monsanto Co. (MON) Shares Sold by Reliance Trust Co. of Delaware
Reliance Trust Co. of Delaware cut its position in shares of Monsanto Co. (NYSE:MON) by 46.1% during the third quarter, Holdings Channel reports. The institutional investor owned 12,015 shares of the company’s stock after selling 10,290 shares during the period. Reliance Trust Co. of Delaware’s holdings in Monsanto were worth $1,228,000 as of its most recent SEC filing.
A number of other large investors also recently added to or reduced their stakes in the stock. WFG Advisors LP boosted its stake in Monsanto by 18.6% in the second quarter. WFG Advisors LP now owns 1,009 shares of the company’s stock worth $104,000 after buying an additional 158 shares in the last quarter. Signaturefd LLC boosted its stake in shares of Monsanto by 62.1% in the second quarter. Signaturefd LLC now owns 1,083 shares of the company’s stock valued at $112,000 after buying an additional 415 shares during the period. Mycio Wealth Partners LLC boosted its stake in shares of Monsanto by 1.1% in the second quarter. Mycio Wealth Partners LLC now owns 1,094 shares of the company’s stock valued at $113,000 after buying an additional 12 shares during the period. Pinkerton Retirement Specialists LLC boosted its stake in shares of Monsanto by 1,179.1% in the second quarter. Pinkerton Retirement Specialists LLC now owns 1,100 shares of the company’s stock valued at $114,000 after buying an additional 1,014 shares during the period. Finally, Enterprise Financial Services Corp boosted its stake in shares of Monsanto by 4.5% in the second quarter. Enterprise Financial Services Corp now owns 1,335 shares of the company’s stock valued at $138,000 after buying an additional 57 shares during the period. 73.94% of the stock is currently owned by hedge funds and other institutional investors.
Shares of Monsanto Co. (NYSE:MON) traded up 0.35% during trading on Tuesday, reaching $102.39. The company had a trading volume of 1,261,307 shares. The firm has a 50-day moving average price of $100.97 and a 200-day moving average price of $104.18. The company has a market capitalization of $44.84 billion, a P/E ratio of 34.27 and a beta of 1.01. Monsanto Co. has a 52-week low of $83.73 and a 52-week high of $114.26.
Monsanto (NYSE:MON) last issued its quarterly earnings results on Wednesday, October 5th. The company reported $0.07 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.02) by $0.09. Monsanto had a return on equity of 46.07% and a net margin of 9.89%. The firm had revenue of $2.56 billion for the quarter, compared to analyst estimates of $2.38 billion. During the same period last year, the company earned ($0.19) EPS. The firm’s quarterly revenue was up 8.8% on a year-over-year basis. On average, analysts predict that Monsanto Co. will post $4.73 EPS for the current fiscal year.
TRADEMARK VIOLATION NOTICE: This article was originally posted by Financial Market News and is the propert of of Financial Market News. If you are reading this article on another website, it was copied illegally and republished in violation of United States & international trademark and copyright legislation. The correct version of this article can be accessed at http://www.financial-market-news.com/monsanto-co-mon-shares-sold-by-reliance-trust-co-of-delaware/1209517/.
Several equities research analysts have issued reports on the stock. Jefferies Group reaffirmed a “buy” rating on shares of Monsanto in a research note on Tuesday, September 6th. Zacks Investment Research raised shares of Monsanto from a “strong sell” rating to a “hold” rating in a research note on Tuesday, September 6th. Monness Crespi & Hardt raised shares of Monsanto from a “neutral” rating to a “buy” rating and lifted their target price for the stock from $106.93 to $130.00 in a research note on Monday, August 8th. Sanford C. Bernstein reaffirmed a “sell” rating on shares of Monsanto in a research note on Thursday, September 15th. Finally, BMO Capital Markets set a $128.00 target price on shares of Monsanto and gave the stock a “buy” rating in a research note on Thursday, September 15th. Two research analysts have rated the stock with a sell rating, nine have issued a hold rating and fifteen have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus price target of $114.06.
In other news, EVP Steven Mizell sold 310 shares of the firm’s stock in a transaction dated Monday, October 10th. The stock was sold at an average price of $103.09, for a total value of $31,957.90. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Kerry J. Preete sold 2,745 shares of the firm’s stock in a transaction dated Thursday, November 17th. The stock was sold at an average price of $100.96, for a total value of $277,135.20. Following the completion of the transaction, the executive vice president now owns 50,056 shares in the company, valued at $5,053,653.76. The disclosure for this sale can be found here. 0.88% of the stock is owned by insiders.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Co. (NYSE:MON).
Receive News & Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related companies with MarketBeat.com's FREE daily email newsletter.